Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Correspondence

Correspondence to editorial on “Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma”

Yu-Hang Ye, Shao-Lai Zhou

Clin Mol Hepatol. 2025;31(1):e90-e92. Published online November 11, 2024

DOI: https://doi.org/10.3350/cmh.2024.0998

View: 922 Download: 21

Original Article

Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma

Yu-Hang Ye, Hao-Yang Xin, Jia-Li Li, Ning Li, Si-Yuan Pan, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Peng-Cheng Wang, Chu-Bin Luo, Rong-Qi Sun, Jia Fan, Jian Zhou, Zheng-Jun Zhou, Shao-Lai Zhou

Clin Mol Hepatol. 2024;30(4):914-928. Published online August 6, 2024

DOI: https://doi.org/10.3350/cmh.2024.0296

View: 3155 Download: 210 Web of Science: 3 Crossref: 5

Liver Pathology

Histopathology of a benign bile duct lesion in the liver: Morphologic mimicker or precursor of intrahepatic cholangiocarcinoma

Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(3):400-405. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0105

View: 13427 Download: 325 Web of Science: 16 Crossref: 13

Case Report

Detection of distant metastasis to skeletal muscle by ¹⁸F-FDG-PET in a case of intrahepatic cholangiocarcinoma

Se Kyung Park, Young Seok Kim, Sang Gyune Kim, Jae Young Jang, Jong Ho Moon, Moon Sung Lee, Boo Sung Kim, Eun Suk Koh, Jung Mi Park

Clin Mol Hepatol. 2010;16(3):325-328. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.325

View: 7371 Download: 44 Crossref: 11

5

Intrahepatic cholangiocarcinoma associated with Clonorchis sinensis infection

Yoon Mi Jeen , So Young Jin

Clin Mol Hepatol. 2009;15(4):524-527. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.524

View: 4842 Download: 38 Crossref: 1

Original Article

Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target

Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang

Received October 9, 2024 Accepted February 7, 2025

DOI: https://doi.org/10.3350/cmh.2024.0895 [Accepted]

View: 6956 Download: 297

1 |

Viewed By 11849	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7399	MAFLD: How is it different from NAFLD?
Viewed By 6543	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5677	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Viewed By 5279	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 349	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 331	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 219	MAFLD: How is it different from NAFLD?
Cited By 114	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 110	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Search